357 related articles for article (PubMed ID: 11353786)
1. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.
Hu YL; Tee MK; Goetzl EJ; Auersperg N; Mills GB; Ferrara N; Jaffe RB
J Natl Cancer Inst; 2001 May; 93(10):762-8. PubMed ID: 11353786
[TBL] [Abstract][Full Text] [Related]
2. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
4. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
5. Regulator of G-protein signalling expression and function in ovarian cancer cell lines.
Hurst JH; Mendpara N; Hooks SB
Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070
[TBL] [Abstract][Full Text] [Related]
6. Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer.
Fujita T; Miyamoto S; Onoyama I; Sonoda K; Mekada E; Nakano H
Cancer Lett; 2003 Mar; 192(2):161-9. PubMed ID: 12668280
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Pustilnik TB; Estrella V; Wiener JR; Mao M; Eder A; Watt MA; Bast RC; Mills GB
Clin Cancer Res; 1999 Nov; 5(11):3704-10. PubMed ID: 10589790
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer.
Schulte KM; Beyer A; Köhrer K; Oberhäuser S; Röher HD
Int J Cancer; 2001 Apr; 92(2):249-56. PubMed ID: 11291053
[TBL] [Abstract][Full Text] [Related]
9. Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.
Song Y; Wu J; Oyesanya RA; Lee Z; Mukherjee A; Fang X
Clin Cancer Res; 2009 Jan; 15(2):492-501. PubMed ID: 19147754
[TBL] [Abstract][Full Text] [Related]
10. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
Bermudez Y; Yang H; Saunders BO; Cheng JQ; Nicosia SV; Kruk PA
Gynecol Oncol; 2007 Sep; 106(3):526-37. PubMed ID: 17559911
[TBL] [Abstract][Full Text] [Related]
11. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.
Ryuto M; Ono M; Izumi H; Yoshida S; Weich HA; Kohno K; Kuwano M
J Biol Chem; 1996 Nov; 271(45):28220-8. PubMed ID: 8910439
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.
Sako A; Kitayama J; Shida D; Suzuki R; Sakai T; Ohta H; Nagawa H
J Surg Res; 2006 Jan; 130(1):94-101. PubMed ID: 16171822
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and E-cadherin in human ovarian cancer: association with ascites fluid accumulation and peritoneal dissemination in mouse ascites model.
Akutagawa N; Nishikawa A; Iwasaki M; Fujimoto T; Teramoto M; Kitajima Y; Endo T; Shibuya M; Kudo R
Jpn J Cancer Res; 2002 Jun; 93(6):644-51. PubMed ID: 12079512
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells.
Hyder SM; Chiappetta C; Stancel GM
Int J Cancer; 2001 May; 92(4):469-73. PubMed ID: 11304678
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization.
An S; Bleu T; Zheng Y; Goetzl EJ
Mol Pharmacol; 1998 Nov; 54(5):881-8. PubMed ID: 9804623
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1.
Shida D; Kitayama J; Yamaguchi H; Okaji Y; Tsuno NH; Watanabe T; Takuwa Y; Nagawa H
Cancer Res; 2003 Apr; 63(7):1706-11. PubMed ID: 12670925
[TBL] [Abstract][Full Text] [Related]
18. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
20. VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.
Wang J; Luo F; Lu JJ; Chen PK; Liu P; Zheng W
Int J Cancer; 2002 Jan; 97(2):163-7. PubMed ID: 11774259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
